Resources From the Webinar on EAGLE study on Varenicline!

On September 13, NAQC hosted a webinar on the findings from the EAGLE study on Varenicline, an FDA-approved medication for tobacco cessation. You may be interested in some of the resources that were shared:
Drug Fact Sheet from the California Smokers Helpline
Article on the EAGLE study
Literature on quitline experience with Varenicline

• Biazzo LL et al. Characteristics and abstinence outcomes among tobacco quitline enrollees using varenicline or nicotine replacement therapy. Nicotine Tob Res. 2010 Jun;12(6):567-73. doi: 10.1093/ntr/ntq045. Epub 2010 Apr 8.
• Smith BJ, et al Smoking Termination Opportunity for inPatients (STOP): superiority of a course of varenicline tartrate plus counselling over counselling alone for smoking cessation: a 12-month randomised controlled trial for inpatients.  Thorax. 2013 May;68(5):485-6. doi: 10.1136/thoraxjnl-2012-202484. Epub 2012 Sep 19.
• Carson KV Safety of varenicline tartrate and counseling versus counseling alone for smoking cessation: a randomized controlled trial for inpatients (STOP study).  Nicotine Tob Res. 2014 Nov;16(11):1495-502. doi: 10.1093/ntr/ntu112. Epub 2014 Jul 16
• Kerkvliet JL et al. Tobacco quitline outcomes by service type.  S D Med. 2014 Jan;67(1):25-9.
• Wong J, et al. A Perioperative Smoking Cessation Intervention With Varenicline, Counseling, and Fax Referral to a Telephone Quitline Versus a Brief Intervention: A Randomized Controlled Trial.  Anesth Analg. 2017 Aug;125(2):571-579. doi: 10.1213/ANE.0000000000001894
• Anthenelli et al.  Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.  Lancet 2016 Apr 22. doi: 10.1016/S0140-6736(16)30272-0 [Epub ahead of print]